Clinical Trial Update: Evaluation of Intravenous N-acetylcysteine to Prevent Contrast Media Induced Nephrotoxicity in an Emergency Center

View source ↗

Summary

A completed clinical trial evaluated intravenous N-acetylcysteine for the prevention of contrast-induced nephrotoxicity in emergency department patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Nephrotoxicity | Status: COMPLETED